Trials / Completed
CompletedNCT03514342
The Effects of Horner's Syndrome Developing After Interscalene Brachial Plexus Block on Autonomic Nervous Activity
The Effects of Difference in Pupil Size Between Bilateral Eyes on Cardiac Sympathetic Nervous Activity Following Interscalene Brachial Plexus Block
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Daegu Catholic University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effects of Horner's syndrome on cardiac autonomic nervous activity after interscalene brachial plexus block. Cardiac autonomic nervous activity and bilateral pupil diameters will be measured in a scotopic light condition, 30 minutes after interscalene brachial plexus block under ultrasound guidance and 15 minutes after the subsequent sitting position.
Detailed description
Stellate ganglia provide sympathetic fibers to the heart. Ipsilateral stellate ganglion block accompanied by interscalene brachial plexus block causes Horner's syndrome presenting with miosis, ptosis, and anhidrosis. The extent of Horner's syndrome can be represented by the difference in pupil diameter between bilateral eyes. Cardiac autonomic nervous activity affected by stellate ganglion block can be measured by calculation of heart rate variability parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Interscalene brachial plexus block | Under ultrasound guidance, the 5th to 7th cervical nerve roots are identified between anterior and middle scalene muscles and subsequently blocked. |
| DRUG | 0.75% ropivacaine | Placement of 25 to 30 ml of 0.75% ropivacaine around the 5th to 7th cervical nerve roots |
Timeline
- Start date
- 2018-06-18
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2018-05-02
- Last updated
- 2021-06-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03514342. Inclusion in this directory is not an endorsement.